Overview

Low Dose Human Chorionic Gonadotropin: Influence on the Endometrium

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
0
Participant gender:
Female
Summary
The purpose of the present study is to assess the influence of the administration of low dose hCG on the endometrium. The study is a randomised trial where 2 groups of patients, undergoing a gonadotropin-releasing hormone antagonist protocol for in vitro fertilization, are studied. In addition to the histological findings, by analysing the correlation of the morphological pattern and gene expression profile of human endometrium on the day of oocyte retrieval in patients of both treatment groups, the investigators want to study the implantation potential.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Universitair Ziekenhuis Brussel
Treatments:
Chorionic Gonadotropin
Menotropins
Criteria
Inclusion Criteria:

- < 36 years on day of randomisation

- FSH < 12 in the early follicular phase

- Normal ultrasound scan

- BMI between 18 and 29 (both inclusive)

- Randomisation at outpatient clinic

Exclusion Criteria:

- Endometriosis ≥ grade 3

- PCO syndrome

- Poor responder

- Endocrine or metabolic abnormalities